A new trading day began on Tuesday, with LAVA Therapeutics NV (NASDAQ: LVTX) stock price up 7.23% from the previous day of trading, before settling in for the closing price of $1.66. LVTX’s price has ranged from $0.85 to $2.00 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 81.88%. With a float of $22.11 million, this company’s outstanding shares have now reached $26.31 million.
LAVA Therapeutics NV (LVTX) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of LAVA Therapeutics NV is 15.94%, while institutional ownership is 27.54%. The most recent insider transaction that took place on Oct 17 ’25, was worth 1,736,263. In this transaction 10% Owner of this company sold 1,181,131 shares at a rate of $1.47, taking the stock ownership to the 2,947,781 shares. Before that another transaction happened on Oct 16 ’25, when Company’s 10% Owner sold 690,239 for $1.49, making the entire transaction worth $1,028,456. This insider now owns 4,128,912 shares in total.
LAVA Therapeutics NV (LVTX) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.13 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.18 per share during the current fiscal year.
LAVA Therapeutics NV (NASDAQ: LVTX) Trading Performance Indicators
Here are LAVA Therapeutics NV’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 12.27. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.38.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.86
Technical Analysis of LAVA Therapeutics NV (LVTX)
The latest stats from [LAVA Therapeutics NV, LVTX] show that its last 5-days average volume of 0.24 million was inferior to 0.24 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 68.83%.
During the past 100 days, LAVA Therapeutics NV’s (LVTX) raw stochastic average was set at 91.59%, which indicates a significant increase from 81.62% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0528 in the past 14 days, which was lower than the 0.0638 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5806, while its 200-day Moving Average is $1.3817. Now, the first resistance to watch is $1.8600. This is followed by the second major resistance level at $1.9400. The third major resistance level sits at $2.0550. If the price goes on to break the first support level at $1.6650, it is likely to go to the next support level at $1.5500. The third support level lies at $1.4700 if the price breaches the second support level.
LAVA Therapeutics NV (NASDAQ: LVTX) Key Stats
With a market capitalization of 46.83 million, the company has a total of 26,305K Shares Outstanding. Currently, annual sales are 11,980 K while annual income is -25,110 K. The company’s previous quarter sales were 0 K while its latest quarter income was -7,190 K.
